Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences

February 10, 2026 - 03:34

Praxis Precision Medicines, Inc., a leader in central nervous system precision neuroscience, has scheduled the release of its fourth quarter and full year 2025 financial results for Thursday, February 19, 2026. The announcement will be made public prior to the opening of the financial markets that day.

Following the release, the company's management will host a conference call and live webcast to discuss the financial performance and provide a comprehensive corporate update. This event will offer investors and analysts direct insight into the company's recent progress and strategic outlook.

In addition to the earnings report, Praxis has confirmed its participation in several upcoming investor conferences. These engagements are part of the company's ongoing commitment to maintaining transparent communication with the investment community and sharing developments in its pipeline of precision neuroscience therapies. The company focuses on developing treatments for psychiatric and neurological disorders by targeting genetic drivers of brain disease.